Since we have previously shown a direct inhibitory effect of platelet-activating factor (PAF) on Cl reabsorption in the medullary thick ascending limb of Henle's loop (TAL), the aim of this study was to extend this effect to the whole TAL and to further investigate the signaling pathway involved. In microperfused cortical TALs, PAF significantly decreased Cl reabsorption by 50.3±6.5%. On the one hand, this effect was not modified in the presence of staurosporine and was not mimicked by phorbol ester; chelating cytosolic Ca by BAPTA/AM failed to suppress the inhibitory effect of PAF on Cl reabsorption; moreover, no significant increase in intracellular Ca concentration could be observed in the presence of PAF on isolated tubules. On the other hand, 8-bromo cyclic GMP mimicked the PAF effect on Cl reabsorption and prevented a further effect of this agent; the PAF effect was significantly reduced by H-8, a cyclic GMP-dependent protein kinase inhibitor; in medullary TALs, PAF significantly increased by twofold cyclic GMP content, an effect inhibited by the PAF antagonist BN 50730, whereas PAF did not significantly modify cAMP content in basal or stimulated conditions. Finally, inhibition of nitric oxide production by NAME or NMMA failed to prevent the effect of PAF on Cl reabsorption.
Introduction
Platelet-activating factor (PAF)l (1-0-allyl-2-acetyl-sn-glycerol-3-phosphocholine) is a ubiquitous autacoid that is involved in many flux; mTAL, medullary thick ascending limb of Henle's loop; NAME, NGnitro-L-arginine methyl ester; NMMA, N mono methyl arginine; NO, nitric oxide; PAF, platelet-activating factor, V, tubular flow rate. patiophysiological events, among which are inflammation and anaphylactic reaction (1) . In the kidney, it was established that PAF decreased the sodium chloride Wransport rate in the medullary thick ascending limb of Henle's loop (mTAL) by a dual manner. first by direct inhibition of the reabsorptive function of the mTAL, as demonstrated in our laboratory on isolated tubules (2) ; and second by decreasing the solute delivery to the mTAL, since PAF was shown to induce a decline of the glomerular filtration rate (3) . These results, combined with the demonstration by Brezis et al. (4) that decreasing the reabsorptive function of the mTAL prevented the epithelium from the damages occurring during hypoxia, allowed us to postulate that PAF may play a role in the preservation of the cell integrity during renal injury (2) .
It is known that the action of PAF on its target cells involves multiple signaling pathways among which are stimulation of tyrosine kinase, stimulation of phospholipase A2, C, or D, and inhibition of adenylate-cyclase (5) . In the glomerulus, it has been reported extensively that PAF increased prostaglandin production via a calcium-mediated stimulation of phospholipase A2 (3) . However, other signaling pathways can be involved in that structure, especially in the glomerular mesangial cells (6) . At variance with those reported for the glomerulus, the results obtained from the mTAL indicated that the PAF-in-duced net chloride flux (Jcl) inhibition did not result from phospholipase A2 activation, neither was it mediated by adenosine (2) . The effect of PAF on mTAL was antagonized by BN 50730, a result in accordance with the recent localization of PAF receptors in the cortical and medullary parts of the kidney (7) .
The aim of the present study was to further investigate the mechanism of action underlying the inhibitory effect of PAF on the TAL reabsorptive function. TAL is involved in two main reabsorptive functions which are sodium chloride reabsorption, contributing to the generation of the corticopapillary gradient, and the reabsorption of the bulk of the filtered calcium and magnesium. Since chloride transport has been shown to be closely correlated to sodium transport as well as to the passive reabsorption of the divalent cations (8, 9) , Jcl, determined on microperfused tubules, was used as the representative parameter of the TAL function. The fact that, in the present study, the inhibitory effect of PAF on Jcl was found to be similar in the cortical TAL (cTAL) and in the mTAL allowed us to investigate the mechanism of action involved in this effect on either segment. The results here obtained showed that the inhibitory effect of PAF on Jc0 (a) did not involve protein kinase C activation; (b) was not associated with any increase in intracellular calcium concentration ([Ca]i); (c) was independent of cyclic AMP content modifications; but (d) was mediated by cyclic GMP, independently of NO production. This study thus brings the first indication that PAF can directly stimulate the cyclic GMP pathway and underlines that, in the kidney, the PAF signaling pathways are different for the glomerulus and for the TAL. Burg et al. (10) and usually used in our laboratory. Briefly, male Swiss white mice, 18-20 g body wt, were killed by cervical dislocation and exsanguinated. Coronal slices were then cut from both kidneys and were immersed immediately in a cold perfusing solution (see composition detailed below) in which 0.4% bovine serum albumin was added. The cTALs were then transferred to a Lucite chamber in which the bath, thermostatically maintained at 36±0.1C, was flowing continuously at about 5 m/min.
Each perfused tubule was allowed to equilibrate during 1 h. After equilibration, a 30-min control period was followed by one or two 30-min experimental periods, during which the luminal fluid was collected every 10 min. Between each period, 10 min was allowed for equilibration. All the tested agents were added into the bath, either since the beginning of the control period or during the experimental period, as mentioned in the text. When the tubules were loaded with BAPTA/AM (acetoxymethyl ester), the perfused tubules were incubated 30 min in the dark at room temperature, in the bathing solution containing 10-5 M BAPTA/AM in dimethylsulfoxide (final dilution 3,000 vol/vol). This incubation solution was then washed out and replaced by the flowing bathing solution before the beginning of the control period.
The composition of the perfusing solution was as follows (mM): NaCl 147, MgCl2 2, CaCl2 1, KCl 2, urea 10, Hepes 10. The composition of the bathing solution was similar, except for a lower NaCl concentration, 142 mM, because of the addition of glucose (5 mM) and Na acetate (5 mM). All the solutions were adjusted to 300 mosmol H20 with urea and to pH 7.39-7.42.
In the collected fluid and perfusate, chloride concentration (Cc and Cp, respectively) was determined by microelectrometric titration (11) .
The tubular flow rate (V) was calculated from the volume of the collected sample, assuming that water reabsorption was negligible in the TAL (12) . The net chloride reabsorption was calculated as J0 = (Cc-CP)
x V. Since, in the cTAL, no evidence was brought that the chloride reabsorption was proportional to the tubular length when the chloride concentration decreased, and because the length of the perfused segments was fairly similar from one experiment to another, the net fluxes were not monitored by this parameter.
Data from the three collections of each 30-min period were pooled and considered as one point. Values (Fig. 2) . Moreover, administration during the experimental period of 10-8-10-7 M PMA, a protein kinase C activator, failed to mimick the inhibi- Chelating cytosolic calcium by 10-5 M BAPTA/AM failed to prevent the PAF-induced decrease of Jcj (Fig. 4) . Nevertheless, the same maneuver completely blocked the inhibitory ef-I C:|nM Role of cyclic GMP. The inhibitory effect of PAF on J0 was mimicked by i0-4 M 8-bromo cyclic GMP (Table I (Table II) .
Cyclic GMP content was determined on isolated mTALs in two series of experiments. In the first one, PAF significantly increased this parameter over the basal values by about twofold, and, in the other one, the PAF-induced increase in cGMP content was significantly reduced in the presence of the PAF antagonist BN 50730 (Fig. 6) . Since an effect of PAF on the transepithelial resistance was recently described in cultured medullary collecting tubules cells (16) (Table IV) , suggesting the presence of a soluble guanylate cyclase activity in this segment. To investigate a possible activation of this enzyme by PAF through NO production, experiments have been performed in the presence of two NO synthase inhibitors, NM-nitro-L-arginine methyl ester (NAME) or N mono methyl arginine (NMMA). Administration of each of these agents, 10-' M in the bath, throughout the experiment failed to impair the inhibitory effect of PAF on J0 (32.8±4.6 vs 52.8±6.2 pmol/min, in the experimental and control period, respectively, n = 7, P < 0.001, Fig. 7 ). Moreover, it was verified that the presence of NAME did not significantly modify Jc1 (53.3±7.7 vs 55.8±8.2 pmol/min, with and without this agent, respectively, n = 5).
Discussion
This study was undertaken to investigate the signaling pathway involved in the PAF-induced decrease of Jcj in the thick ascending limb of Henle's loop. In a previous work (2) (15) with the atrial natriuretic factor, which is known to activate guanylate-cyclase. As (23) . Finally, the absence of interaction between PAF and cyclic AMP allowed us to exclude a possible increase in cyclic GMP content mediated by the PAF-stimulated cyclic AMP production, as reported in bacteria (24) . Absence ofPAF effect on NO synthesis. Evidence exists that the PAF-induced increase in cyclic GMP did not result from a stimulation of NO synthase. First, two different NO synthase inhibitors, at a concentration usually used (25) , failed to abolish the effect of PAF on Jc1 in this study. Second, recent reports (26, 27) have detected in the cTAL and mTAL an inducible but not constitutive NO synthase. The short delay for the response to PAF of Jc0 (Fig. 1) as well as transepithelial voltage (2) is against a possible induction of NO synthase by PAF in this segment. It must be noted, however, that the present results did not bring any evidence for effectiviness of the NO synthase inhibitors in the conditions used here. The absence in TAL of a constitutive NO synthase and the fact that, to this date, no effect of NO synthase activation on TAL transport is available rendered such a control uneasy. Cyclic GMP has been described to be involved in the vasodilatory action of PAF on the renal afferent arteriole (28) . This effect, however, resulted from an activation by PAF of the endothelial, calcium-stimulated NO synthase.
The results presented here thus raise the question of the mechanism of action of PAF on the cyclic GMP production. On the one hand, a PAF receptor cloned from human heart (29) was described to belong to the rhodopsin-type receptor family, suggesting a PAF action on the phosphodiesterase activity rather than on a membranous guanylate cyclase. On the other hand, the fact that, in this work, PAF increased cyclic GMP content in the presence of a nonspecific phosphodiesterase blocker a priori allowed us to rule out a possible inhibition by PAF of this enzyme activity. Other investigations are needed to further elucidate the signal involved in the PAF-induced increase in cyclic GMP production.
In conclusion, the present paper showed that the PAF-induced decrease of Jc0 in the TAL is mediated by cyclic GMP, independent of NO production, indicating that PAF exerted its action on the TAL reabsorptive function through a signaling pathway different from that involved in its glomerular effects.
